Search Femetric

Search peptides, goals, protocols and references

Weight ManagementFat LossBody CompositionGlucose / Insulin

RESEARCH REFERENCE

Pemvidutide

An investigational GLP-1 and glucagon receptor dual agonist studied for obesity and metabolic liver disease.

02

How this works

Pemvidutide is designed to engage GLP-1 and glucagon receptors. Published and sponsor-reported findings are labeled separately as the program develops.

03

Benefits + side effects

Potential Benefits

  • Weight Management
  • Fat Loss
  • Body Composition
  • Glucose / Insulin
10

References

01
MOMENTUM: a study of pemvidutide in adults with overweight or obesityClinicalTrials.gov · 2024
CLINICAL TRIAL

THE SIGNAL · SENT TWICE A MONTH

Stay ahead of the research without living on PubMed.

Peptide references, research worth knowing, new FEMETRIC tools, and meaningful testing updates. Twice a month. No daily emails.
By subscribing, you agree to receive The Signal from FEMETRIC. Unsubscribe anytime.
NEXT RESEARCH ACTION
Was this useful?